"Sativa is the UK’s first medicinal cannabis investment vehicle. After investing in two North American businesses, it is now progressing a UK seed to consumer investment strategy with 100% ownership of businesses involved in the production, testing and compliance, research & development including pharmacology, commercialisation and sales & marketing of medicinal cannabis and cannabidiol products. Two UK businesses, George Botanicals and PhytoVista Laboratories, are already fully operational. The Company intends to add a 7.5-acre cannabis growing and processing facility and has already executed an option agreement over an optimum site."

Meet Our Team

A successful entrepreneur with a proven track record. Read more……


A qualified Chartered Accountant with significant commercial experience… Read more….

Angus Kerr
Angus Kerr
non-Executive Director

An adviser and capital markets professional with nearly 25 years’ experience in global banking Read more……


Mark Blower
Mark Blower
non-Executive Director

An experienced fund manager and corporate financier. Read more….

Jonathan Wearing
Jonathan Wearing

A corporate finance professional Read more….

“Sativa management are expertly supported by an independent advisory board. Investment policy and proposals will be approved by them.”

Medical Advisory Board

Dr Brown is an award-winning Consultant at The Royal Marsden Hospital specialising in pain medicine and anaesthetics.  Read More

Sir Alasdair Breckenridge has a medical career as a pharmacologist that totals close to 60 years.  Read More

Dr. Peter Feldschreiber is dually qualified as a barrister and physician. Read More…

Dr. Ungar qualified in medicine, with additional qualifications in medical biochemistry at the Royal Free Hospital. Read More…



PeterHouse Capital

Financial PR

Abchurch Communications


Hill Dickinson